These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 16478921

  • 1. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML, Chen HW, Tsai JP, Lee YP, Shih YC, Chang CM, Ting CC.
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH, Hoover SK, Susskind BM, Barrett SK, Bear HD.
    Cancer Res; 1992 Mar 15; 52(6):1386-92. PubMed ID: 1531782
    [Abstract] [Full Text] [Related]

  • 3. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

  • 4. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI, Nahill SR, Maciaszek JW, Welsh RM.
    J Immunol; 1992 Aug 15; 149(4):1326-33. PubMed ID: 1500720
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 6. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 7. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb 15; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 8. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
    Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh CL, Yeh YC, Chou AH, Chang SR, Hsiao KN, Yu FW, Chen HW.
    J Leukoc Biol; 2007 Aug 15; 82(2):354-60. PubMed ID: 17505023
    [Abstract] [Full Text] [Related]

  • 9. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1803-11. PubMed ID: 10845601
    [Abstract] [Full Text] [Related]

  • 10. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
    Hadley GA, Bartlett ST, Via CS, Rostapshova EA, Moainie S.
    J Immunol; 1997 Oct 15; 159(8):3748-56. PubMed ID: 9378961
    [Abstract] [Full Text] [Related]

  • 11. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
    Jin B, Scott JL, Vadas MA, Burns GF.
    Immunology; 1989 Apr 15; 66(4):570-6. PubMed ID: 2541074
    [Abstract] [Full Text] [Related]

  • 12. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
    Maile R, Pop SM, Tisch R, Collins EJ, Cairns BA, Frelinger JA.
    Eur J Immunol; 2006 Feb 15; 36(2):397-410. PubMed ID: 16402405
    [Abstract] [Full Text] [Related]

  • 13. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
    Lefrancois L, Klein JR, Paetkau V, Bevan MJ.
    J Immunol; 1984 Apr 15; 132(4):1845-50. PubMed ID: 6230394
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
    Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T.
    J Immunol; 1991 Feb 01; 146(3):1077-82. PubMed ID: 1671050
    [Abstract] [Full Text] [Related]

  • 15. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A, Mercier BC, Mbitikon-Kobo FM, Arpin C, Teoh DY, McMichael A, Marvel J, Bonnefoy-Bérard N.
    Eur J Immunol; 2009 Oct 01; 39(10):2673-81. PubMed ID: 19634192
    [Abstract] [Full Text] [Related]

  • 16. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q, Yang X, Pins M, Javonovic B, Kuzel T, Kim SJ, Parijs LV, Greenberg NM, Liu V, Guo Y, Lee C.
    Cancer Res; 2005 Mar 01; 65(5):1761-9. PubMed ID: 15753372
    [Abstract] [Full Text] [Related]

  • 17. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H, Kofler D, Hombach A, Abken H.
    Cancer Res; 2007 Mar 01; 67(5):2265-73. PubMed ID: 17332357
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions.
    Mehal WZ, Sheikh SZ, Gorelik L, Flavell RA.
    Int Immunol; 2005 May 01; 17(5):531-8. PubMed ID: 15824070
    [Abstract] [Full Text] [Related]

  • 19. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F, Garcia-Sanz JA, Moriggl R, Wild MT.
    J Immunol; 1999 Jan 01; 162(1):209-14. PubMed ID: 9886388
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD.
    J Immunol; 1992 Jun 15; 148(12):3847-56. PubMed ID: 1602133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.